SCHEDULE 13G/A: BlackRock Discloses 6.5% Stake in Accuray Inc. Common Stock

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.5% beneficial ownership stake in Accuray Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 6,718,114 shares of Accuray Inc. common stock.
• This ownership represents 6.5% of Accuray Inc.'s total outstanding common stock.
• BlackRock holds sole voting power over 6,663,014 shares and sole dispositive power over 6,718,114 shares.
• The filing indicates that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Accuray Inc.
• The filing was made by BlackRock, Inc. as a parent holding company, with several subsidiaries identified as potentially holding the securities, including BlackRock Advisors, LLC and BlackRock Fund Advisors.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of a significant passive ownership stake by a major institutional investor, BlackRock, in Accuray Inc. While the disclosure itself is neutral and factual, the presence of a large institutional holder can be perceived as a positive signal of confidence in the company's long-term prospects.

Positives

• The disclosure of a significant 6.5% stake by a major institutional investor like BlackRock can be viewed as a vote of confidence in Accuray Inc.'s long-term prospects.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Accuray Inc., mitigating potential risks associated with activist investor intervention from this specific holding.

Future Outlook

NA

Management Comments

• BlackRock, Inc. certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This Schedule 13G filing by BlackRock, a major global asset manager, reflects its passive investment in Accuray Inc., a company operating in the medical device industry, specifically in radiation oncology systems. Such filings are routine disclosures for large institutional investors crossing ownership thresholds and do not inherently indicate broader industry trends, though they confirm continued institutional interest in the sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which may influence investor sentiment and perception of the company's stability and attractiveness.

Key Dates

Keywords

Accuray Inc., BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices